知识库计划质控系统的高效训练、优化与验证用于放疗临床试验
本研究基于INTERTECC方案分析86例宫颈癌调强放疗患者,通过去除次优计划构建优化训练集并自动生成KBP计划,在35例验证集中KBPFINAL计划在所有方案特异性DVH指标上优于人工计划,胃肠道毒性NTCP均值更低(48.7% vs 53.8%,P<.001),白细胞最低值更高(2.77 vs 2.49 k/mL,P<.001)。
要点
- KBP系统可高效训练并优化用于放疗临床试验计划质控。
- 验证集中KBPFINAL计划在所有方案特异性DVH cutpoint上优于人工计划。
- KBPFINAL计划胃肠道毒性NTCP更低、血液学毒性概率降低。
核心结论
- KBP系统能以最小工作量高效训练和优化用于放疗临床试验。
- 患者特异性计划质控改善了方案特异性剂量学终点。
研究设计与样本
- 分析2家机构86例IB-IVA期宫颈癌调强放疗患者,依据INTERTECC方案标准。
- 初始DVH估计模型用全部86例计划训练,优化训练集通过去除次优计划构建。
- 从86例中识别30例强调盆腔骨髓保护、另30例强调肠道保护(9例重叠)构建DVH估计模型。
- 在51例训练样本中选择最佳自动计划routine(KBPFINAL),在35例验证集中比较原始计划与KBPFINAL计划。
- 采用配对t检验比较计划集差异。
主要发现
- KBPFINAL计划在验证集所有方案特异性DVH cutpoint上优于人工计划。
- 胃肠道毒性平均NTCP:KBPFINAL计划48.7% vs 验证集计划53.8%,P<.001。
- 估计平均白细胞最低值:KBPFINAL计划2.77 vs 2.49 k/mL,P<.001,提示血液学毒性概率降低。
关键数值与推荐
- 方案使用计划靶体积和2个主要危及器官:盆腔骨髓(PBM)和肠道;次要危及器官为直肠和膀胱。
- PBM保护比较方案规定的剂量学cutpoint V10(PBM接受至少10 Gy的体积百分比)和V20(PBM接受至少20 Gy的体积百分比)与未过滤预测。
- 肠道保护比较V40(肠道接受至少40 Gy的绝对体积)和V45(肠道接受至少45 Gy的绝对体积)。
- 为获得可交付KBP计划,优化模型须告知患者特异性优化目标和/或优先级(自动计划routine)。
- 组成4个强调不同权衡的候选routine,开发脚本自动用每个routine重新计划多名患者。
临床怎么用
- KBP系统可用于放疗临床试验的计划质量控质,以最小工作量高效训练和优化。
- 患者特异性计划质控可改善方案特异性剂量学终点。
- 自动计划routine可用于批量重新计划并选择最佳满足方案目标的routine。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To demonstrate an efficient method for training and validation of a knowledge-based planning (KBP) system as a radiation therapy clinical trial plan quality-control system. METHODS AND MATERIALS: We analyzed 86 patients with stage IB through IVA cervical cancer treated with intensity modulated radiation therapy at 2 institutions according to the standards of the INTERTECC (International Evaluation of Radiotherapy Technology Effectiveness in Cervical Cancer, National Clinical Trials Network identifier: 01554397) protocol. The protocol used a planning target volume and 2 primary organs at risk: pelvic bone marrow (PBM) and bowel. Secondary organs at risk were rectum and bladder. Initial unfiltered dose-volume histogram (DVH) estimation models were trained using all 86 plans. Refined training sets were created by removing sub-optimal plans from the unfiltered sample, and DVH estimation models… and DVH estimation models were constructed by identifying 30 of 86 plans emphasizing PBM sparing (comparing protocol-specified dosimetric cutpoints V10 (percentage volume of PBM receiving at least 10 Gy dose) and V20 (percentage volume of PBM receiving at least 20 Gy dose) with unfiltered predictions) and another 30 of 86 plans emphasizing bowel sparing (comparing V40 (absolute volume of bowel receiving at least 40 Gy dose) and V45 (absolute volume of bowel receiving at least 45 Gy dose), 9 in common with the PBM set). To obtain deliverable KBP plans, refined models must inform patient-specific optimization objectives and/or priorities (an auto-planning "routine"). Four candidate routines emphasizing different tradeoffs were composed, and a script was developed to automatically re-plan multiple patients with each routine. After selection of the routine that best met protocol objectives in the 51-patient training sample (KBPFINAL), protocol-specific DVH metrics and normal tissue complication probability were compared for original versus KBPFINAL plans across the 35-patient validation set. Paired t tests were used to test differences between planning sets. RESULTS: KBPFINAL plans outperformed manual planning across the validation set in all protocol-specific DVH cutpoints. The mean normal tissue complication probability for gastrointestinal toxicity was lower for KBPFINAL versus validation-set plans (48.7% vs 53.8%, P<.001). Similarly, the estimated mean white blood cell count nadir was higher (2.77 vs 2.49 k/mL, P<.001) with KBPFINAL plans, indicating lowered probability of hematologic toxicity. CONCLUSIONS: This work demonstrates that a KBP system can be efficiently trained and refined for use in radiation therapy clinical trials with minimal effort. This patient-specific plan quality control resulted in improvements on protocol-specific dosimetric endpoints.
引用
- Li N, Carmona R, Sirak I, et al. Highly Efficient Training, Refinement, and Validation of a Knowledge-based Planning Quality-Control System for Radiation Therapy Clinical Trials. Int J Radiat Oncol Biol Phys. 2016. PMID: 27979445. doi:10.1016/j.ijrobp.2016.10.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。